RXMAPPER
LIVE

Serial Number

97414158

Owner

RxMapper, LLC

Attorney

Alexis P. Grilli

Filing Date

May 17, 2022

Add to watchlist:

No watchlists yet
View on USPTO

RXMAPPER Trademark

Serial Number: 97414158

RXMAPPER is a trademark filed by RxMapper, LLC on May 17, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

RxMapper, LLC (3 trademarks)

9375 E. Shea Blvd., Suite 134
Scottsdale, AZ 85260

Entity Type: 16

Trademark Details

Filing Date

May 17, 2022

Registration Date

Not Registered

Published for Opposition

July 11, 2023

Goods & Services

Consulting services in the field of pharmaceutical research; Technical research in the field of pharmaceutical studies; Providing online non-downloadable software for the structural and functional analysis of genomes for medical and pharmaceutical consultation, advice, and analysis; Providing online non-downloadable computer software for the structural and functional analysis of genomes for medical and pharmaceutical consultation, advice, and analysis; providing online non-downloadable computer software for pharmaceutical drug utilization services; Providing online non-downloadable computer software for the structural and functional analysis of genomes for retrieving and displaying health information; Providing online non-downloadable computer software for the structural and functional analysis of genomes for use in health assessment services, namely, providing medical advice, pharmaceutical drug and drug utilization analysis services all for treatment and diagnostic purposes; providing online non-downloadable computer software for the structural and functional analysis of genomes for use in determining pharmaceutical cost management; Providing online non downloadable computer software for the structural and functional analysis of genomes; scientific research in the field of the structural and functional analysis of genomes; providing online non-downloadable computer software for DNA and RNA sequencing for medical purposes; providing online non-downloadable computer software for DNA and RNA analysis services for medical treatment purposes

Downloadable computer software for the structural and functional analysis of genomes for medical and pharmaceutical consultation, advice, and analysis; Downloadable mobile software for the structural and functional analysis of genomes for medical and pharmaceutical consultation, advice, and analysis; Downloadable computer software for the structural and functional analysis of genomes for pharmaceutical drug utilization consultation, advice, and analysis; Downloadable mobile software for the structural and functional analysis of genomes for pharmaceutical drug utilization consultation, advice, and analysis; Downloadable computer applications for retrieving and displaying health information; Downloadable mobile applications for retrieving and displaying health information; Downloadable computer software creating a database in the field of pharmaceutical drug and drug utilization information and featuring inputting and collection of data and information all for medical treatment and diagnostic purposes; Downloadable computer software for pharmaceutical cost management; Downloadable mobile software for analysis of pharmaceutical cost management; Downloadable computer software for the structural and functional analysis of genomes; Downloadable computer software for analysis of DNA and RNA sequencing for medical purposes

Medical services; Telemedicine services; Clinical medical consultation services; Medical and pharmaceutical consultation, advice, and medical analysis services for the diagnosis of conditions and diseases for genomic maladies; Medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by non-genomic health care physicians and health care professionals for the diagnosis and treatment of diseases and conditions; genetic analysis services, namely, DNA and RNA sequencing for medical purposes; Pharmaceutical advice services; Medical advice services; Pharmaceutical drug advice; Pharmaceutical drug utilization advice; Providing health information; Providing pharmaceutical drug utilization information via a website; Health care services, namely, providing health care information services, namely, providing a database featuring information in the field of genetic analysis, pharmaceutical drug, and drug utilization; providing health care information services, namely, providing a database featuring information of data and information all for medical treatment and diagnostic purposes; Health assessment services, namely medical diagnosis and medical treatment services of conditions and diseases for genomic maladies; Health assessment services, namely, providing pharmaceutical drug and, drug utilization for diagnosis and treatment of conditions and diseases for genomic maladies; Genomic benefit management services, namely, medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by non-genomic health care physicians and health care professionals for the diagnosis and treatment of diseases and conditions; managed medical care and pharmaceutical consultation; Providing an Internet website portal featuring medical information in the fields of medicine and pharmaceuticals

Pharmaceutical cost management services and drug utilization review services; Business consulting, business management, and business cost analysis of medical diagnosis, medical treatment, pharmaceutical cost management and drug utilization; Providing pharmaceutical cost management information via a website

Filing History

TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2026 TROA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2026 EXRA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Feb 18, 2026 INCD
ASSIGNED TO EXAMINER
Jan 18, 2026 DOCK
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 14, 2026 AITU
SOU EXTENSION 4 GRANTED
Sep 5, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 5, 2025 EXT4
TEAS REQUEST TO DIVIDE RECEIVED
Sep 5, 2025 ERTD
TEAS STATEMENT OF USE RECEIVED
Sep 5, 2025 EISU
SOU TEAS EXTENSION RECEIVED
Sep 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 6, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 5, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 5, 2024 EXRA
SOU EXTENSION 2 GRANTED
Sep 5, 2024 EX2G
SOU EXTENSION 2 FILED
Sep 5, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 5, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 5, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 5, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 5, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 11, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 21, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 7, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 23, 2022 NWOS
NEW APPLICATION ENTERED
May 20, 2022 NWAP